FdaApplication

ANDA 078202

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNEPHRON PHARMACEUTICALS CORPORATION
application_typeANDA
approval_date2009-03-30

Products (2)

ProductActive ingredientStrengthDosage form
BUDESONIDEBUDESONIDE0.25MG/2MLSUSPENSION;INHALATION
BUDESONIDEBUDESONIDE0.5MG/2MLSUSPENSION;INHALATION

2 products